HIV-1 protease-induced apoptosis

. 2014 May 20 ; 11 () : 37. [epub] 20140520

Jazyk angličtina Země Velká Británie, Anglie Médium electronic

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/pmid24886575

BACKGROUND: Apoptosis is one of the presumptive causes of CD4+ T cell depletion during HIV infection and progression to AIDS. However, the precise role of HIV-1 in this process remains unexplained. HIV-1 protease (PR) has been suggested as a possible factor, but a direct link between HIV-1 PR enzymatic activity and apoptosis has not been established. RESULTS: Here, we show that expression of active HIV-1 PR induces death in HeLa and HEK-293 cells via the mitochondrial apoptotic pathway. This conclusion is based on in vivo observations of the direct localization of HIV-1 PR in mitochondria, a key player in triggering apoptosis. Moreover, we observed an HIV-1 PR concentration-dependent decrease in mitochondrial membrane potential and the role of HIV-1 PR in activation of caspase 9, PARP cleavage and DNA fragmentation. In addition, in vitro data demonstrated that HIV-1 PR mediates cleavage of mitochondrial proteins Tom22, VDAC and ANT, leading to release of AIF and Hsp60 proteins. By using yeast two-hybrid screening, we also identified a new HIV-1 PR interaction partner, breast carcinoma-associated protein 3 (BCA3). We found that BCA3 accelerates p53 transcriptional activity on the bax promoter, thus elevating the cellular level of pro-apoptotic Bax protein. CONCLUSION: In summary, our results describe the involvement of HIV-1 PR in apoptosis, which is caused either by a direct effect of HIV-1 PR on mitochondrial membrane integrity or by its interaction with cellular protein BCA3.

Zobrazit více v PubMed

Arnoult D, Petit F, Lelievre JD, Estaquier J. Mitochondria in HIV-1-induced apoptosis. Biochem Biophys Res Commun. 2003;304:561–574. doi: 10.1016/S0006-291X(03)00629-6. PubMed DOI

Arnoult D, Viollet L, Petit F, Lelievre JD, Estaquier J. HIV-1 triggers mitochondrion death. Mitochondrion. 2004;4:255–269. doi: 10.1016/j.mito.2004.06.010. PubMed DOI

Cummins NW, Badley AD. Mechanisms of HIV-associated lymphocyte apoptosis: 2010. Cell Death Dis. 2010;1:e99. doi: 10.1038/cddis.2010.77. PubMed DOI PMC

Kroemer G, Galluzzi L, Brenner C. Mitochondrial membrane permeabilization in cell death. Physiol Rev. 2007;87:99–163. doi: 10.1152/physrev.00013.2006. PubMed DOI

Ferri KF, Jacotot E, Blanco J, Este JA, Kroemer G. Mitochondrial control of cell death induced by HIV-1-encoded proteins. Ann N Y Acad Sci. 2000;926:149–164. PubMed

Ferri KF, Jacotot E, Leduc P, Geuskens M, Ingber DE, Kroemer G. Apoptosis of syncytia induced by the HIV-1-envelope glycoprotein complex: influence of cell shape and size. Exp Cell Res. 2000;261:119–126. doi: 10.1006/excr.2000.5062. PubMed DOI

Jacotot E, Ravagnan L, Loeffler M, Ferri KF, Vieira HL, Zamzami N, Costantini P, Druillennec S, Hoebeke J, Briand JP, Irinopoulou T, Daugas E, Susin SA, Cointe D, Xie ZH, Reed JC, Roques BP, Kroemer G. The HIV-1 viral protein R induces apoptosis via a direct effect on the mitochondrial permeability transition pore. J Exp Med. 2000;191:33–46. doi: 10.1084/jem.191.1.33. PubMed DOI PMC

Jacotot E, Ferri KF, El Hamel C, Brenner C, Druillennec S, Hoebeke J, Rustin P, Métivier D, Lenoir C, Geuskens M, Vieira HL, Loeffler M, Belzacq AS, Briand JP, Zamzami N, Edelman L, Xie ZH, Reed JC, Roques BP, Kroemer G. Control of mitochondrial membrane permeabilization by adenine nucleotide translocator interacting with HIV-1 viral protein rR and Bcl-2. J Exp Med. 2001;193:509–519. doi: 10.1084/jem.193.4.509. PubMed DOI PMC

Kaplan AH, Swanstrom R. Human immunodeficiency virus type 1 Gag proteins are processed in two cellular compartments. Proc Natl Acad Sci. 1991;88:4528–4532. doi: 10.1073/pnas.88.10.4528. PubMed DOI PMC

Baum EZ, Bebernitz GA, Gluzman Y. Isolation of mutants of human immunodeficiency virus protease based on the toxicity of the enzyme in Escherichia coli. Proc Natl Acad Sci. 1990;87:5573–5577. doi: 10.1073/pnas.87.14.5573. PubMed DOI PMC

Strack PR, Frey MW, Rizzo CJ, Cordova B, George HJ, Meade R, Ho SP, Corman J, Tritch R, Korant BD. Apoptosis mediated by HIV protease is preceded by cleavage of Bcl-2. Proc Natl Acad Sci U S A. 1996;93:9571–9576. doi: 10.1073/pnas.93.18.9571. PubMed DOI PMC

Blanco R, Carrasco L, Ventoso I. Cell killing by HIV-1 protease. J Biol Chem. 2003;278:1086–1093. doi: 10.1074/jbc.M205636200. PubMed DOI

Adams LD, Tomasselli AG, Robbins P, Moss B, Heinrikson RL. HIV-1 protease cleaves actin during acute infection of human T-lymphocytes. AIDS Res Hum Retroviruses. 1992;8:291–295. doi: 10.1089/aid.1992.8.291. PubMed DOI

Shoeman RL, Sachse C, Honer B, Mothes E, Kaufmann M, Traub P. Cleavage of human and mouse cytoskeletal and sarcomeric proteins by human immunodeficiency virus type 1 protease. Actin, desmin, myosin, and tropomyosin. AmJ Pathol. 1993;142:221–230. PubMed PMC

Honer B, Shoeman RL, Traub P. Human immunodeficiency virus type 1 protease microinjected into cultured human skin fibroblasts cleaves vimentin and affects cytoskeletal and nuclear architecture. J Cell Sci. 1991;100(Pt 4):799–807. PubMed

Snasel J, Shoeman R, Horejsi M, Hruskova-Heidingsfeldova O, Sedlacek J, Ruml T, Pichova I. Cleavage of vimentin by different retroviral proteases. Arch Biochem Biophys. 2000;377:241–245. doi: 10.1006/abbi.2000.1776. PubMed DOI

Ventoso I, Blanco R, Perales C, Carrasco L. HIV-1 protease cleaves eukaryotic initiation factor 4G and inhibits cap-dependent translation. Proc Natl Acad Sci U S A. 2001;98:12966–12971. doi: 10.1073/pnas.231343498. PubMed DOI PMC

Nie Z, Phenix BN, Lum JJ, Alam A, Lynch DH, Beckett B, Krammer PH, Sekaly RP, Badley AD. HIV-1 protease processes procaspase 8 to cause mitochondrial release of cytochrome c, caspase cleavage and nuclear fragmentation. Cell Death Differ. 2002;9:1172–1184. doi: 10.1038/sj.cdd.4401094. PubMed DOI

Nie Z, Bren GD, Vlahakis SR, Schimnich AA, Brenchley JM, Trushin SA, Warren S, Schnepple DJ, Kovacs CM, Loutfy MR, Douek DC, Badley AD. Human immunodeficiency virus type 1 protease cleaves procaspase 8 in vivo. J Virol. 2007;81:6947–6956. doi: 10.1128/JVI.02798-06. PubMed DOI PMC

Nie Z, Bren GD, Rizza SA, Badley AD. HIV protease cleavage of procaspase 8 is necessary for death of HIV-infected cells. Open Virol J. 2008;2:1–7. doi: 10.2174/1874357900802010001. PubMed DOI PMC

Alvarez E, Castello A, Menendez-Arias L, Carrasco L. HIV protease cleaves poly(A)-binding protein. Biochem J. 2006;396:219–226. doi: 10.1042/BJ20060108. PubMed DOI PMC

Jäger S, Cimermancic P, Gulbahce N, Johnson JR, McGovern KE, Clarke SC, Shales M, Mercenne G, Pache L, Li K, Hernandez H, Jang GM, Roth SL, Akiva E, Marlett J, Stephens M, D'Orso I, Fernandes J, Fahey M, Mahon C, O'Donoghue AJ, Todorovic A, Morris JH, Maltby DA, Alber T, Cagney G, Bushman FD, Young JA, Chanda SK, Sundquist WI. et al.Global landscape of HIV-human protein complexes. Nature. 2012;481:365–370. PubMed PMC

Sainski AM, Natesampillai S, Cummins NW, Bren GD, Taylor J, Saenz DT, Poeschla EM, Badley AD. The HIV-1-specific protein Casp8p41 induces death of infected cells through Bax/Bak. J Virol. 2011;85:7965–7975. doi: 10.1128/JVI.02515-10. PubMed DOI PMC

Algeciras-Schimnich A, Belzacq-Casagrande AS, Bren GD, Nie Z, Taylor JA, Rizza SA, Brenner C, Badley AD. Analysis of HIV protease killing through caspase 8 reveals a novel interaction between caspase 8 and mitochondria. Open Virol J. 2007;1:39–46. PubMed PMC

Burger A, Li H, Zhang XK, Pienkowska M, Venanzoni M, Vournakis J, Papas T, Seth A. Breast cancer genome anatomy: correlation of morphological changes in breast carcinomas with expression of the novel gene product Di12. Oncogene. 1998;16:327–333. doi: 10.1038/sj.onc.1201517. PubMed DOI

Kitching R, Li H, Wong MJ, Kanaganayakam S, Kahn H, Seth A. Characterization of a novel human breast cancer associated gene (BCA3) encoding an alternatively spliced proline-rich protein. Biochim Biophys Acta. 2003;1625:116–121. doi: 10.1016/S0167-4781(02)00562-6. PubMed DOI

Sastri M, Barraclough DM, Carmichael PT, Taylor SS. A-kinase-interacting protein localizes protein kinase A in the nucleus. Proc Natl Acad Sci U S A. 2005;102:349–354. doi: 10.1073/pnas.0408608102. PubMed DOI PMC

Gao F, Cheng J, Shi T, Yeh ETH. Neddylation of a breast cancer-associated protein recruits a class III histone deacetylase that represses NF[kappa]B-dependent transcription. Nat Cell Biol. 2006;8:1171–1177. doi: 10.1038/ncb1483. PubMed DOI

Gao N, Asamitsu K, Hibi Y, Ueno T, Okamoto T. AKIP1 enhances NF-kappaB-dependent gene expression by promoting the nuclear retention and phosphorylation of p65. J Biol Chem. 2008;283:7834–7843. doi: 10.1074/jbc.M710285200. PubMed DOI

Gao N, Hibi Y, Cueno M, Asamitsu K, Okamoto T. A-kinase-interacting protein 1 (AKIP1) acts as a molecular determinant of PKA in NF − +¦B signaling. J Biol Chem. 2010;285:28097–28104. doi: 10.1074/jbc.M110.116566. PubMed DOI PMC

Leung TH-Y, Ngan HY-S. Interaction of TAp73 and breast cancerÇôAssociated gene 3 enhances the sensitivity of cervical cancer cells in response to irradiation-induced apoptosis. Cancer Res. 2010;70:6486–6496. doi: 10.1158/0008-5472.CAN-10-0688. PubMed DOI

Sastri M, Haushalter KJ, Panneerselvam M, Chang P, Fridolfsson H, Finley JC, Ng D, Schilling JM, Miyanohara A, Day ME, Hakozaki H, Petrosyan S, Koller A, King CC, Darshi M, Blumenthal DK, Ali SS, Roth DM, Patel HH, Taylor SS. A kinase interacting protein (AKIP1) is a key regulator of cardiac stress. Proc Natl Acad Sci. 2013;110:E387–E396. doi: 10.1073/pnas.1221670110. PubMed DOI PMC

Rumlová M, Křížová I, Hadravová R, Doležal M, Strohalmová K, Keprová A, Pichová I, Ruml T. Breast carcinoma associated protein – a novel binding partner of Mason-Pfizer monkey virus protease. J Gen Virol. 2014. doi:10.1099/vir.0.064345-0. PubMed

Wlodawer A, Gustchina A. Structural and biochemical studies of retroviral proteases. Biochim Biophys Acta. 2000;1477:16–34. doi: 10.1016/S0167-4838(99)00267-8. PubMed DOI

Dunn BM, Goodenow MM, Gustchina A, Wlodawer A. Retroviral proteases. Genome Biol. 2002;3(4):REVIEWS3006. PubMed PMC

Cao X, Deng X, May WS. Cleavage of Bax to p18 Bax accelerates stress-induced apoptosis, and a cathepsin-like protease may rapidly degrade p18 Bax. Blood. 2003;102:2605–2614. doi: 10.1182/blood-2003-01-0211. PubMed DOI

Gao G, Dou QP. N-terminal cleavage of bax by calpain generates a potent proapoptotic 18-kDa fragment that promotes bcl-2-independent cytochrome C release and apoptotic cell death. J Cell Biochem. 2000;80:53–72. PubMed

Wood DE, Thomas A, Devi LA, Berman Y, Beavis RC, Reed JC, Newcomb EW. Bax cleavage is mediated by calpain during drug-induced apoptosis. Oncogene. 1998;17:1069–1078. doi: 10.1038/sj.onc.1202034. PubMed DOI

Wood DE, Newcomb EW. Cleavage of Bax enhances its cell death function. Exp Cell Res. 2000;256:375–382. doi: 10.1006/excr.2000.4859. PubMed DOI

Miyashita T, Reed JC. Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell. 1995;80:293–299. doi: 10.1016/0092-8674(95)90412-3. PubMed DOI

Tang Y, Zhao W, Chen Y, Zhao Y, Gu W. Acetylation is indispensable for p53 activation. Cell. 2008;133:612–626. doi: 10.1016/j.cell.2008.03.025. PubMed DOI PMC

Vaseva AV, Moll UM. The mitochondrial p53 pathway. Biochim Biophys Acta. 2009;1787:414–420. doi: 10.1016/j.bbabio.2008.10.005. PubMed DOI PMC

Carbonari M, Pesce AM, Cibati M, Modica A, Dell’Anna L, D’Offizi G, Angelici A, Uccini S, Modesti A, Fiorilli M. Death of bystander cells by a novel pathway involving early mitochondrial damage in human immunodeficiency virus-related lymphadenopathy. Blood. 1997;90:209–216. PubMed

Castedo M, Macho A, Zamzami N, Hirsch T, Marchetti P, Uriel J, Kroemer G. Mitochondrial perturbations define lymphocytes undergoing apoptotic depletion in vivo. Eur J Immunol. 1995;25:3277–3284. doi: 10.1002/eji.1830251212. PubMed DOI

Macho A, Castedo M, Marchetti P, Aguilar JJ, Decaudin D, Zamzami N, Girard PM, Uriel J, Kroemer G. Mitochondrial dysfunctions in circulating T lymphocytes from human immunodeficiency virus-1 carriers. Blood. 1995;86:2481–2487. PubMed

Greenspan HC, Aruoma OI, Arouma O. Could oxidative stress initiate programmed cell death in HIV infection? A role for plant derived metabolites having synergistic antioxidant activity. Chem Biol Interact. 1994;91:187–197. doi: 10.1016/0009-2797(94)90039-6. PubMed DOI

Ohta A, Nishiyama Y. Mitochondria and viruses. Mitochondrion. 2011;11:1–12. doi: 10.1016/j.mito.2010.08.006. PubMed DOI PMC

Green DR, Kroemer G. The pathophysiology of mitochondrial cell death. Science. 2004;305:626–629. doi: 10.1126/science.1099320. PubMed DOI

Genini D, Sheeter D, Rought S, Zaunders JJ, Susin SA, Kroemer G, Richman DD, Carson DA, Corbeil J, Leoni LM. HIV induces lymphocyte apoptosis by a p53-initiated, mitochondrial-mediated mechanism. FASEB J. 2000;15:5–6. PubMed

Welker R, Hohenberg H, Tessmer U, Huckhagel C, Krausslich HG. Biochemical and structural analysis of isolated mature cores of human immunodeficiency virus type 1. J Virol. 2000;74:1168–1177. doi: 10.1128/JVI.74.3.1168-1177.2000. PubMed DOI PMC

Roberts MM, Copeland TD, Oroszlan S. In situ processing of a retroviral nucleocapsid protein by the viral proteinase. Protein Eng. 1991;4:695–700. doi: 10.1093/protein/4.6.695. PubMed DOI

Rumlova M, Ruml T, Pohl J, Pichova I. Specific in vitro cleavage of Mason-Pfizer monkey virus capsid protein: evidence for a potential role of retroviral protease in early stages of infection. Virology. 2003;310:310–318. doi: 10.1016/S0042-6822(03)00128-4. PubMed DOI

Milan K, Bray J, Pavlína Ř, Klára Š, Jiří B, Jana P, Mammano F, Lubomír R, Jan K. Molecular analysis of the HIV-1 resistance development: enzymatic activities, crystal structures, and thermodynamics of nelfinavir-resistant HIV protease mutants. J Mol Biol. 2007;374:1005–1016. doi: 10.1016/j.jmb.2007.09.083. PubMed DOI

Vlach J, Lipov J, Rumlova M, Veverka V, Lang J, Srb P, Knejzlik Z, Pichova I, Hunter E, Hrabal R, Ruml T. D-retrovirus morphogenetic switch driven by the targeting signal accessibility to Tctex-1 of dynein. Proc Natl Acad Sci U S A. 2008;105:10565–10570. doi: 10.1073/pnas.0801765105. PubMed DOI PMC

Chandra D, Choy G, Deng X, Bhatia B, Daniel P, Tang DG. Association of active caspase 8 with the mitochondrial membrane during apoptosis: potential roles in cleaving BAP31 and caspase 3 and mediating mitochondrion-endoplasmic reticulum cross talk in etoposide-induced cell death. Mol Cell Biol. 2004;24:6592–6607. doi: 10.1128/MCB.24.15.6592-6607.2004. PubMed DOI PMC

Chandra D, Tang DG. Mitochondrially localized active caspase-9 and caspase-3 result mostly from translocation from the cytosol and partly from caspase-mediated activation in the organelle. Lack of evidence for Apaf-1-mediated procaspase-9 activation in the mitochondria. J Biol Chem. 2003;278:17408–17420. doi: 10.1074/jbc.M300750200. PubMed DOI

Dohi T, Beltrami E, Wall NR, Plescia J, Altieri DC. Mitochondrial survivin inhibits apoptosis and promotes tumorigenesis. J Clin Invest. 2004;114:1117–1127. doi: 10.1172/JCI200422222. PubMed DOI PMC

Vermes I, Haanen C, Steffens-Nakken H, Reutelingsperger C. A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V. J Immunol Methods. 1995;184:39–51. doi: 10.1016/0022-1759(95)00072-I. PubMed DOI

vE M, Ramaekers FC, Schutte B, Reutelingsperger CP. A novel assay to measure loss of plasma membrane asymmetry during apoptosis of adherent cells in culture. Cytometry. 1996;24:131–139. doi: 10.1002/(SICI)1097-0320(19960601)24:2<131::AID-CYTO5>3.0.CO;2-M. PubMed DOI

Dorrie J, Sapala K, Zunino SJ. Carnosol-induced apoptosis and downregulation of Bcl-2 in B-lineage leukemia cells. Cancer Lett. 2001;170:33–39. doi: 10.1016/S0304-3835(01)00549-3. PubMed DOI

Kulkarni GV, Lee W, Seth A, McCulloch CA. Role of mitochondrial membrane potential in concanavalin A-induced apoptosis in human fibroblasts. Exp Cell Res. 1998;245:170–178. doi: 10.1006/excr.1998.4245. PubMed DOI

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...